CORC

浏览/检索结果: 共10条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis 期刊论文
MEDICINE, 2016, 卷号: 95, 期号: 47
作者:  Ma, Hong;  Xie, Wen;  Gao, Zhiliang;  Chen, Guofeng;  Zhu, Youfu
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/04
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues 期刊论文
GUT, 2016, 卷号: 65, 期号: 2
作者:  Fan, Rong;  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Bai, Xuefan
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/05
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study 期刊论文
JOURNAL OF HEPATOLOGY, 2016, 卷号: 65, 期号: 4
作者:  Sun, Jian;  Ma, Hong;  Xie, Qing;  Xie, Yao;  Sun, Yongtao
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues 期刊论文
Gut, 2016, 卷号: 65, 期号: 2, 页码: 313-320
作者:  Fan, Rong;  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Bai, Xuefan
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/03
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues 期刊论文
GUT, 2016, 卷号: 65, 页码: 313-320
作者:  Fan, Rong[1,2];  Sun, Jian[1,2];  Yuan, Quan[3];  Xie, Qing[4];  Bai, Xuefan[5]
收藏  |  浏览/下载:20/0  |  提交时间:2019/04/24
Ruthenium complexes bearing an unsymmetrical pincer ligand with a 2-hydroxypyridylmethylene fragment: active catalysts for transfer hydrogenation of ketones. 期刊论文
Dalton Trans., 2016, 卷号: Vol.45 No.11, 页码: 4828-4834
作者:  Shi, Jing;  Hu, Bowen;  Gong, Dawei;  Shang, Shu;  Hou, Guangfeng
收藏  |  浏览/下载:10/0  |  提交时间:2019/02/27
A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 144 会议论文
作者:  Xu, Jinghang;  Yu, Yanyan;  Si, Chongwen;  Zeng, Zheng;  Li, Jun
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/13
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis 期刊论文
MEDICINE, 2016, 卷号: 95, 期号: 47
作者:  Ma, Hong;  Zeng, Minde;  Han, Ying;  Yan, Huiping;  Tang, Hong
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/13
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study 期刊论文
JOURNAL OF HEPATOLOGY, 2016, 卷号: 65, 期号: 4
作者:  Sun, Jian;  Ma, Hong;  Xie, Qing;  Xie, Yao;  Sun, Yongtao
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/06
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues 期刊论文
GUT, 2016, 卷号: 65, 期号: 2
作者:  Fan, Rong;  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Bai, Xuefan
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/06


©版权所有 ©2017 CSpace - Powered by CSpace